Accessibility navigation


Immunogenetics of drug-induced skin blistering disorders. Part II: Synthesis

Bowman, C. and Delrieu, O. (2009) Immunogenetics of drug-induced skin blistering disorders. Part II: Synthesis. Pharmacogenomics, 10 (5). pp. 779-816. ISSN 1462-2416

Full text not archived in this repository.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

To link to this item DOI: 10.2217/pgs.09.23

Abstract/Summary

The overall immunopathogenesis relevant to a large series of disorders caused by a drug or its associated hyperimmune condition is discussed based upon examining the genetics of severe drug-induced bullous skin problems (sporadic idiosyncratic adverse events including Stevens-Johnson syndrome and Toxic epidermal necrolysis). New results from an exemplar study on shared precipitating and perpetuating inner causes with other related disease phenotypes including aphtous stomatitis, Behcets, erythema multiforme, Hashimoto's thyroiditis, pemphigus, periodic fevers, Sweet's syndrome and drug-induced multisystem hypersensitivity are presented. A call for a collaborative, wider demographic profiling and deeper immunotyping in suggested future work is made.

Item Type:Article
Refereed:Yes
Divisions:Faculty of Life Sciences > School of Biological Sciences
ID Code:9569
Uncontrolled Keywords:EM, HLA, hypersensitivity, Lyell syndrome, MHC, maculopapular erythema, pharmacogenetics, rash, SJS, TEN, HUMAN-LEUKOCYTE ANTIGEN, TUMOR-NECROSIS-FACTOR, MAJOR, HISTOCOMPATIBILITY COMPLEX, INFLAMMATORY-BOWEL-DISEASE, HLA CLASS-II, SYSTEMIC-LUPUS-ERYTHEMATOSUS, STEVENS-JOHNSON-SYNDROME, FEBRILE, NEUTROPHILIC DERMATOSIS, TOXIC EPIDERMAL NECROLYSIS, IL-1 RECEPTOR, ANTAGONIST

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation